Contact
Please use this form to send email to PR contact of this press release:
Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA008 in Pigmented Villonodular Synovitis (PVNS)
TO:
Please use this form to send email to PR contact of this press release:
Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA008 in Pigmented Villonodular Synovitis (PVNS)
TO: